Based on the aforementioned exploration of the literature, we hypothesized that an exosome-mediated transfer of miR-221-3p in ADR-resistant BC cells may be involved in BC drug resistance, by regulating PIK3R1 and the PI3K/AKT signaling pathway. Here, AKT1 is linked to breast cancer.